drugset
drugset / Trial / NCT03345589

A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis

NCT03345589 ↗

Phase 4 Unknown 40 enrolled West China Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the effect of 18-22mg/kg/d Ursodeoxycholic in refractory Primary Biliary Cholangitis

Timeline

Start
2018-01-30
Primary completion
2018-12-01
Completion
2019-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ursodeoxycholic Unknown — —

Indications

primary biliary cholangitis